The Minimal Clinically Important Difference, Substantial Clinical Benefit, and Patient-Acceptable Symptomatic State after Medial Patellofemoral Ligament Reconstruction

PURPOSE: To define the minimal clinically important difference (MCID), substantial clinical benefit (SCB) and patient-acceptable symptomatic state (PASS) for patient-reported outcome measures (PROMs) after medial patellofemoral ligament reconstruction (MPFLR) and to investigate the role of preoperat...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Justin M., Huddleston, Hailey P., Alzein, Mohamad M., Wong, Stephanie E., Forsythe, Brian, Verma, Nikhil N., Cole, Brian J., Yanke, Adam B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042905/
https://www.ncbi.nlm.nih.gov/pubmed/35494257
http://dx.doi.org/10.1016/j.asmr.2021.12.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042905/
https://www.ncbi.nlm.nih.gov/pubmed/35494257
http://dx.doi.org/10.1016/j.asmr.2021.12.009

Ejemplares similares